First Time Loading...

Burning Rock Biotech Ltd
NASDAQ:BNR

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
NASDAQ:BNR
Watchlist
Price: 0.7281 USD 4.01% Market Closed
Updated: Mar 29, 2024

Burning Rock Biotech Ltd
Operating Income

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Burning Rock Biotech Ltd
Operating Income Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Burning Rock Biotech Ltd
NASDAQ:BNR
Operating Income
¥-980.4m
CAGR 3-Years
-80%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Operating Income
¥-12B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Operating Income
¥-3B
CAGR 3-Years
-19%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Operating Income
¥5.5B
CAGR 3-Years
201%
CAGR 5-Years
99%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Operating Income
¥9.9B
CAGR 3-Years
38%
CAGR 5-Years
46%
CAGR 10-Years
47%
Imeik Technology Development Co Ltd
SZSE:300896
Operating Income
¥1.4B
CAGR 3-Years
59%
CAGR 5-Years
72%
CAGR 10-Years
N/A

See Also

What is Burning Rock Biotech Ltd's Operating Income?
Operating Income
-980.4m CNY

Based on the financial report for Dec 31, 2022, Burning Rock Biotech Ltd's Operating Income amounts to -980.4m CNY.

What is Burning Rock Biotech Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-52%

Over the last year, the Operating Income growth was -23%. The average annual Operating Income growth rates for Burning Rock Biotech Ltd have been -80% over the past three years , -52% over the past five years .